Request for regulatory guidance for cancer cachexia intervention trials
- PMID: 26675232
- PMCID: PMC4670733
- DOI: 10.1002/jcsm.12083
Request for regulatory guidance for cancer cachexia intervention trials
References
-
- von Haehling S, Anker SD. Treatment of cachexia: an overview of recent developments. Int J Cardiol. 2015;184:736–742. - PubMed
-
- Crawford J, Dalton JT, Hancock ML, Johnston MA, Steiner M. Enobosarm, a selective androgen receptor modulator (SARM), increases lean body mass (LBM) in advanced non-small cell lung cancer patients in two pivotal, international Phase 3 trials. J Cachexia Sarcopenia Muscle. 2014;5:35–78. (Abstract) - PubMed
-
- https://clinicaltrials.gov/ct2/show/NCT01355497 (accessed 11/07/2015)
LinkOut - more resources
Full Text Sources
Other Literature Sources
